JP2022525261A - ビスタ結合抗体およびその使用 - Google Patents

ビスタ結合抗体およびその使用 Download PDF

Info

Publication number
JP2022525261A
JP2022525261A JP2022501107A JP2022501107A JP2022525261A JP 2022525261 A JP2022525261 A JP 2022525261A JP 2022501107 A JP2022501107 A JP 2022501107A JP 2022501107 A JP2022501107 A JP 2022501107A JP 2022525261 A JP2022525261 A JP 2022525261A
Authority
JP
Japan
Prior art keywords
seq
chain variable
variable region
antibody
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022501107A
Other languages
English (en)
Japanese (ja)
Inventor
ルイス ケリー，ライアン
メータ，ニシャント
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xyence Therapeutics Inc
Original Assignee
Xyence Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xyence Therapeutics Inc filed Critical Xyence Therapeutics Inc
Publication of JP2022525261A publication Critical patent/JP2022525261A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2022501107A 2019-03-12 2020-03-12 ビスタ結合抗体およびその使用 Pending JP2022525261A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962817268P 2019-03-12 2019-03-12
US62/817,268 2019-03-12
PCT/US2020/022461 WO2020186098A1 (en) 2019-03-12 2020-03-12 Vista-binding antibodies and uses thereof

Publications (1)

Publication Number Publication Date
JP2022525261A true JP2022525261A (ja) 2022-05-11

Family

ID=72428026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022501107A Pending JP2022525261A (ja) 2019-03-12 2020-03-12 ビスタ結合抗体およびその使用

Country Status (5)

Country Link
EP (1) EP3976654A1 (zh)
JP (1) JP2022525261A (zh)
CN (1) CN114729039A (zh)
IL (1) IL286285A (zh)
WO (1) WO2020186098A1 (zh)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011248088B2 (en) * 2010-05-04 2015-06-25 Merrimack Pharmaceuticals, Inc. Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
CN103975060B (zh) * 2011-09-30 2021-04-13 中外制药株式会社 离子浓度依赖性结合分子文库
US11649285B2 (en) * 2016-08-03 2023-05-16 Bio-Techne Corporation Identification of VSIG3/VISTA as a novel immune checkpoint and use thereof for immunotherapy

Also Published As

Publication number Publication date
WO2020186098A1 (en) 2020-09-17
IL286285A (en) 2021-10-31
EP3976654A1 (en) 2022-04-06
CN114729039A (zh) 2022-07-08

Similar Documents

Publication Publication Date Title
TWI788327B (zh) 能夠結合cd137和腫瘤抗原的雙特異性結合分子及其用途
TWI706960B (zh) 能夠結合cd19和cd3的雙特異性雙抗體及其用途
TWI718098B (zh) 三特異性結合分子及其使用方法
JP2022137054A (ja) ＮＫｐ４６結合タンパク質の可変領域
CN110066338B (zh) 作为T细胞衔接器的双特异性IgG抗体
JP2022512865A (ja) 相同二量体型二重特異性抗体およびその調製方法と使用
JP2019523017A (ja) Ｃｄ３結合抗体
JP2018524326A (ja) 多重特異的ｎｋエンゲイジャータンパク質
CA2963718A1 (en) Antigen binding molecules comprising a tnf family ligand trimer
JP2022513432A (ja) 免疫細胞活性化のための二重特異性抗体
AU2019225740A1 (en) Antibody variable domains targeting CD33, and use thereof
EP2970485A1 (en) Tetravalent bispecific antibodies
TW202012440A (zh) 包含4-1bbl之靶向her2的抗原結合分子
EP3755721A1 (en) Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use
AU2022259766A1 (en) Multispecific heavy chain antibodies with modified heavy chain constant regions
TWI814758B (zh) 雙特異性ｃｄ１６-結合分子及其在疾病治療中的用途
CN111971090B (zh) 双特异性egfr/cd16抗原结合蛋白
US20220144961A1 (en) Cd27-binding antibodies and uses thereof
JP2022525261A (ja) ビスタ結合抗体およびその使用
WO2020186111A2 (en) Vista-binding antibodies and uses thereof
US20220144953A1 (en) Vista-binding antibodies and uses thereof
WO2023186100A1 (zh) 抗ror1的抗体及其用途
WO2023051727A1 (zh) 结合cd3的抗体及其用途
TWI838621B (zh) 具有經修飾重鏈恆定區之多特異性重鏈抗體
WO2022037582A1 (zh) 抗cd3和抗cldn-18.2双特异性抗体及其用途